Tom Lawry talks about Machine Learning and Microsoft AI for Good in Healthcare
Deploying \”AI for Good\” In The Life Sciences — Tom Lawry, National Director for Artificial Intelligence, Health & Life Sciences, Microsoft, joins me on ideaXme to discuss how they are deploying artificial intelligence \”at scale\”, across the major organizations responsible for delivery quality, next generation healthcare to millions of patients and customers — #Ideaxme #Microsoft #ArtificialIntelligence #MachineLearning #DeepLearning #Health #Healthcare #Wellness #Medicine #Pharmacy #Hospitals #Nursing #Insurance #Diagnostics #Data #Moonshots #Biotechnology #Longevity #LifeExtension #Aging #IraPastor #Bioquark #Regenerage
Ira Pastor interviews Tom Lawry. He is the National Director of Artificial Intelligence – Health & Life Sciences, at Microsoft.
Ira Pastor Comments
In recent years, we’ve heard a lot about the trio of artificial intelligence (AI), machine learning (ML), and deep learning (DL) and their applications (primarily for drug discovery and development). This is in reference to how university labs, startups, and other organizations are using these tools in order to guide the rational drug-design process or better select patients in a clinical trial.
We will now look at the other end of the spectrum. This is the view of their potential when deployed in the \”scale\” of mega-enterprises that are responsible for delivering quality healthcare of the next generation to millions of clients.
Tom Lawry is the National Director of Artificial Intelligence – Health & Life Sciences for Microsoft. He is a strategic adviser to providers, payers and life sciences organizations in the Americas.
He is focused on the technological, process, and cultural redesign that will lead to Intelligent Health Systems, which better empowers patients, consumers, and clinicians.